Associate Director

InnoHK Centre for Translational Stem Cell Biology (InnoHK CTSCB) leads global innovation in regenerative medicine, driving stem cell innovation to achieve real-world impact. Through partnerships with the University of Hong Kong and the University of Cambridge, with support from the Innovation and Technology Commission, we transform pioneering discoveries into innovative applications and therapeutic solutions. Our patented Expanded Potential Stem Cell (EPSC) is a breakthrough technology that enables the generation of every human cell type, from both embryonic and extra-embryonic lineages. This unique capability empowers our multidisciplinary teams to accelerate the development of next-generation therapies, intelligent drug screening, precision medicine, and advanced cell-based therapies. Our state-of-the-art organoid systems and personalized disease models further streamline drug discovery, opening new pathways for safer and more effective healthcare solutions. Driven by our vision for healthy longevity and a spirit of collaboration, InnoHK CTSCB brings together leading experts from around the world, fostering a vibrant culture of innovation. We are dedicated to translating cutting-edge research into life-changing medicine, building a healthier future for all.